|
시장보고서
상품코드
1907927
리포솜 시장 : 유형별, 구조별, 지질 조성별, 조합 기술별, 약물 부하 방법별, 용도별, 투여 경로별, 최종 사용자별, 지역별Liposomes Market, By Type, By Structure, By Lipid Composition, By Technique of Preparation, By Drug Loading Method, By Application, By Route of Administration, By End User, By Geography |
||||||
리포솜 시장은 2025년에 53억 4,000만 달러로 평가되었고, 2032년까지 100억 8,000만 달러에 이를 것으로 예측됩니다. 2025-2032년 연평균 복합 성장률(CAGR) 9.5%로 성장할 전망입니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 시장 규모(2025년) | 53억 4,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측 기간 CAGR(2025-2032년) | 9.50% | 예측 금액(2032년) | 100억 8,000만 달러 |
세계의 리포솜 시장은 의약품 및 생명공학 산업에서 급속히 진화하는 분야이며, 치료 효과를 높이기 위해 인지질 기반의 소포 구조를 활용한 고급 약물 전달 시스템이 특징입니다.
생체적합성 및 생분해성을 갖춘 캐리어인 리포솜은 생물학적 이용 능력을 대폭 향상시키면서 부작용을 최소화하는 표적 약물 전달 메커니즘을 제공함으로써 의약품 업계에 혁명을 가져왔습니다. 수상 코어를 하나 이상의 인지질 이중층으로 둘러싸는 이 미세한 구형 소포는 친수성 및 소수성 약물, 단백질, 펩티드 및 유전 물질을 캡슐화하는 다목적 플랫폼입니다.
시장 확대의 배경에는 만성 질환 증가, 개인화된 의료에 대한 수요 증가, 나노 기술 기반의 약물 전달 시스템에 대한 많은 투자가 포함됩니다. 종양학, 감염, 안과학, 백신 개발 등 광범위한 분야에서 응용되는 리포솜은 다양한 의료 영역에서 치료 성과 향상에 현저한 잠재력을 보여줍니다.
첨단 제조 기술의 통합 및 혁신적인 리포솜 제형에 대한 규제 당국의 승인이 결합되어, 이 시장은 현대 의약품 개발 전략의 중요한 요소로서의 지위를 확립하고 차세대 약물 전달 솔루션을 활용하려는 기존 제약 회사와 신흥 생명 공학 기업 모두에서 큰 주목을 받고 있습니다.
시장 역학
세계의 리포솜 시장은 몇 가지 강력한 시장 성장 촉진요인에 의해 견인되고 있습니다. 주요 요인은 세계적으로 증가하는 암과 만성 질환의 유병률이며, 이에 대응하기 위해서는 리포솜 약물 전달 시스템이 유일하게 제공할 수 있는 보다 효과적이고 표적화된 치료 개입이 필요합니다. 노인 인구 증가, 헬스케어 지출의 확대, 그리고 진보적인 약물 전달 메커니즘에 대한 인식 증가가 함께 시장 확대에 크게 기여하고 있습니다.
원격 부하 기술과 스텔스 리포솜 개발 등 리포솜 제조 공정의 기술적 진보는 제품의 안정성과 치료 효과를 향상시키고 제약 기업이 리포솜 제제에 많은 투자를 하는 원동력이 되고 있습니다. 그러나 리포솜 제품과 관련된 높은 개발 및 제조 비용, 시장 출시까지의 시간을 연장시키는 복잡한 규제 승인 프로세스, 제품의 품질 및 균일성을 유지하면서 생산을 스케일 업하는 기술적 과제 등 시장은 현저한 제약에도 직면하고 있습니다.
기존 리포솜 제제의 특허 만료 및 대체 약물 전달 시스템과의 치열한 경쟁도 추가적인 과제가 되고 있습니다. 이러한 제약이 있음에도 불구하고, 유전자 치료, 백신 개발, 맞춤형 의료 분야에서 리포솜의 용도 확대로부터 큰 기회가 태어나고 있습니다.
희귀질환 치료에 대한 관심이 높아지고, 신흥 시장에서의 리포솜 제형의 채용 확대, 화장품 및 영양 보조 식품 분야에서의 잠재적 용도 가능성은 수익성이 높은 성장 경로를 나타냅니다. 제약기업 및 연구기관과의 전략적 제휴뿐만 아니라 나노기술 연구를 지원하는 정부의 이니셔티브는 리포솜 약물 전달 시스템 시장 확대 및 혁신에 바람직한 환경을 창출하고 있습니다.
이 보고서의 주요 특징
- 본 보고서는 세계의 리포솜 시장을 상세하게 분석하여 2024년을 기준 연도로 한 예측 기간(2025-2032년) 시장 규모 및 CAGR을 제공합니다.
- 또한 각 부문의 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인 및 억제요인과 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
- 세계 리포솜 시장의 주요 기업 프로파일은 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등 다음 매개 변수를 기반으로 게시됩니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자 및 기업 경영진은 향후 제품 출시, 제휴, 시장 확대, 마케팅 전술에 대한 충분한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- '세계 리포솜 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
- 이해관계자는 세계 리포솜 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적 및 전제조건
- 분석 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의 및 범위
- 주요 요약
제3장 시장 역학, 규제 및 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 출시 및 승인
- PEST 분석
- Porter's Five Forces 분석
- 기업 합병 및 인수(M&A) 시나리오
- 업계 동향
제4장 세계의 리포솜 시장 : 유형별(2020-2032년)
- 기존 리포솜
- PEG화 리포솜
- 리간드 표적형 리포솜
- 장시간 순환형(스텔스) 리포솜
- pH 감수성 리포솜
- 온도 감수성 리포솜
- 양이온성 리포솜
제5장 세계의 리포솜 시장 : 구조별(2020-2032년)
- 다층 소포
- 소형 일층 베시클
- 대형 일층 베시클
- 거대 단층 소포
제6장 세계의 리포솜 시장 : 지질 조성별(2020-2032년)
- 인지질 기반 리포솜
- 콜레스테롤 강화형 리포솜
- 스핑고미엘린계 리포솜
- 합성 지질 리포솜(DSPC, DOPC, 기타)
- 천연 지질 리포솜
제7장 세계의 리포솜 시장 : 조합 기술별(2020-2032년)
- 박막 수화법
- 역상 증발법
- 에탄올 주입법
- 마이크로유체 기술에 근거한 제조
- 세제 제거법
- 동결 융해법
- 고압 균질화
제8장 세계의 리포솜 시장 : 약물 부하 방법별(2020-2032년)
- 수동적 부하
- 능동적 부하(pH 구배, 황산암모늄 구배)
제9장 세계의 리포솜 시장 : 용도별(2020-2032년)
- 약물 전달
- 종양학
- 감염증
- 심혈관 질환
- 신경질환
- 피부과학
- 유전자 도입
- 백신 배달
- 화장품 및 퍼스널케어
- 영양보조식품
- 진단 및 영상 진단
제10장 세계의 리포솜 시장 : 투여 경로별(2020-2032년)
- 정맥내 투여
- 근육내
- 피하
- 경구
- 외용
- 흡입
제11장 세계의 리포솜 시장 : 최종 사용자별(2020-2032년)
- 제약 및 바이오테크놀러지 기업
- 학술기관 및 연구기관
- 병원 및 진료소
- 화장품 및 퍼스널케어 제조업체
- 의약품 개발 및 제조 업무 수탁 기관(CRO/CMO)
제12장 세계의 리포솜 시장 : 지역별(2020-2032년)
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카 국가
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동 국가
- 아프리카
- 남아프리카
- 북아프리카
- 중앙 아프리카
제13장 경쟁 구도
- Gilead Sciences
- Johnson and Johnson
- Sun Pharmaceutical Industries
- Pacira BioSciences
- Luye Pharma Group
- Takeda Pharmaceutical Company
- Teva Pharmaceutical Industries
- Novartis
- Ipsen
- Bristol Myers Squibb
- Pfizer
- Merck
- Evonik Health Care
- Fujifilm
- Polymun Scientific
제14장 애널리스트의 제안
- 기회
- 애널리스트의 견해
- 일관된 기회 지도(COM)
제15장 참고문헌 및 분석 방법
- 참고문헌
- 분석 방법
- Coherent Market Insights에 대해
Liposomes Market is estimated to be valued at USD 5.34 Bn in 2025 and is expected to reach USD 10.08 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.5% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 5.34 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 9.50% | 2032 Value Projection: | USD 10.08 Bn |
The global liposomes market represents a rapidly evolving segment within the pharmaceutical and biotechnology industries, characterized by sophisticated drug delivery systems that leverage phospholipid-based vesicular structures to enhance therapeutic efficacy.
Liposomes, as biocompatible and biodegradable carriers, have revolutionized the pharmaceutical landscape by offering targeted drug delivery mechanisms that significantly improve bioavailability while minimizing adverse effects. These microscopic spherical vesicles, composed of one or more phospholipid bilayers surrounding an aqueous core, serve as versatile platforms for encapsulating both hydrophilic and lipophilic drugs, proteins, peptides, and genetic materials.
The market's expansion is driven by increasing prevalence of chronic diseases, growing demand for personalized medicine, and substantial investments in nanotechnology-based drug delivery systems. With applications spanning oncology, infectious diseases, ophthalmology, and vaccine development, liposomes have demonstrated remarkable potential in enhancing therapeutic outcomes across diverse medical fields.
The integration of advanced manufacturing technologies, coupled with regulatory approvals for innovative liposomal formulations, has positioned this market as a critical component of modern pharmaceutical development strategies, attracting significant attention from both established pharmaceutical companies and emerging biotechnology firms seeking to capitalize on next-generation drug delivery solutions.
Market Dynamics
The global liposomes market is propelled by several compelling drivers, primarily the escalating prevalence of cancer and chronic diseases worldwide, which necessitates more effective and targeted therapeutic interventions that liposomal drug delivery systems uniquely provide. The growing geriatric population, coupled with increasing healthcare expenditure and rising awareness about advanced drug delivery mechanisms, significantly contributes to market expansion.
Technological advancements in liposome manufacturing processes, including remote loading techniques and stealth liposome development, have enhanced product stability and therapeutic efficacy, driving pharmaceutical companies to invest heavily in liposomal formulations. However, the market faces notable restraints including high development and manufacturing costs associated with liposomal products, complex regulatory approval processes that extend time-to-market, and technical challenges related to scale-up production while maintaining product quality and consistency.
Patent expirations of established liposomal drugs and intense competition from alternative drug delivery systems pose additional challenges. Despite these constraints, significant opportunities emerge from the expanding applications of liposomes in gene therapy, vaccine development, and personalized medicine sectors.
The growing focus on rare disease treatments, increasing adoption of liposomal formulations in emerging markets, and potential applications in cosmetics and nutraceuticals present lucrative growth avenues. Strategic collaborations between pharmaceutical companies and research institutions, along with government initiatives supporting nanotechnology research, create favorable conditions for market expansion and innovation in liposomal drug delivery systems.
Key Features of the Study
- This report provides in-depth analysis of the global liposomes market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global liposomes market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Gilead Sciences, Johnson and Johnson, Sun Pharmaceutical Industries, Pacira BioSciences, Luye Pharma Group, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Novartis, Ipsen, Bristol Myers Squibb, Pfizer, Merck, Evonik Health Care, Fujifilm, and Polymun Scientific
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global liposomes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global liposomes market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2020 - 2032)
- Conventional Liposomes
- PEGylated Liposomes
- Ligand-Targeted Liposomes
- Long-Circulating (Stealth) Liposomes
- pH-Sensitive Liposomes
- Temperature-Sensitive Liposomes
- Cationic Liposomes
- Structure Insights (Revenue, USD Bn, 2020 - 2032)
- Multilamellar Vesicles
- Small Unilamellar Vesicles
- Large Unilamellar Vesicles
- Giant Unilamellar Vesicles
- Lipid Composition Insights (Revenue, USD Bn, 2020 - 2032)
- Phospholipid-Based Liposomes
- Cholesterol-Enriched Liposomes
- Sphingomyelin-Based Liposomes
- Synthetic Lipid Liposomes (DSPC, DOPC, others)
- Natural Lipid Liposomes
- Technique of Preparation Insights (Revenue, USD Bn, 2020 - 2032)
- Thin Film Hydration
- Reverse-Phase Evaporation
- Ethanol Injection
- Microfluidics-Based Production
- Detergent Removal
- Freeze-Thaw Method
- High-Pressure Homogenization
- Drug Loading Method Insights (Revenue, USD Bn, 2020 - 2032)
- Passive Loading
- Active Loading (pH Gradient, Ammonium Sulfate Gradient)
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Drug Delivery
- Oncology
- Infectious Diseases
- Cardiovascular Diseases
- Neurological Disorders
- Dermatology
- Gene Delivery
- Vaccine Delivery
- Cosmetics and Personal Care
- Nutraceuticals
- Diagnostics and Imaging
- Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Intravenous
- Intramuscular
- Subcutaneous
- Oral
- Topical
- Inhalation
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Hospitals and Clinics
- Cosmetics and Personal Care Manufacturers
- Contract Research and Manufacturing Organizations (CROs/CMOs)
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Gilead Sciences
- Johnson and Johnson
- Sun Pharmaceutical Industries
- Pacira BioSciences
- Luye Pharma Group
- Takeda Pharmaceutical Company
- Teva Pharmaceutical Industries
- Novartis
- Ipsen
- Bristol Myers Squibb
- Pfizer
- Merck
- Evonik Health Care
- Fujifilm
- Polymun Scientific
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Liposomes Market, By Type
- Global Liposomes Market, By Structure
- Global Liposomes Market, By Lipid Composition
- Global Liposomes Market, By Technique of Preparation
- Global Liposomes Market, By Drug Loading Method
- Global Liposomes Market, By Application
- Global Liposomes Market, By Route of Administration
- Global Liposomes Market, By End User
- Global Liposomes Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Liposomes Market, By Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Conventional Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- PEGylated Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ligand-Targeted Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Long-Circulating (Stealth) Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- pH-Sensitive Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Temperature-Sensitive Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cationic Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Liposomes Market, By Structure, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Multilamellar Vesicles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Small Unilamellar Vesicles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Large Unilamellar Vesicles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Giant Unilamellar Vesicles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Liposomes Market, By Lipid Composition, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Phospholipid-Based Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cholesterol-Enriched Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Sphingomyelin-Based Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Synthetic Lipid Liposomes (DSPC, DOPC, others)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Natural Lipid Liposomes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Liposomes Market, By Technique of Preparation, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Thin Film Hydration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Reverse-Phase Evaporation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ethanol Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Microfluidics-Based Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Detergent Removal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Freeze-Thaw Method
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- High-Pressure Homogenization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Liposomes Market, By Drug Loading Method, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Passive Loading
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Active Loading (pH Gradient, Ammonium Sulfate Gradient)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Liposomes Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Drug Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Gene Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Vaccine Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cosmetics and Personal Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Nutraceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Diagnostics and Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Liposomes Market, By Route of Administration, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Inhalation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
11. Global Liposomes Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cosmetics and Personal Care Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Contract Research and Manufacturing Organizations (CROs/CMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
12. Global Liposomes Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Structure, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Structure, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Structure, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Structure, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Structure, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Structure, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Lipid Composition, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technique of Preparation, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Drug Loading Method, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
13. Competitive Landscape
- Gilead Sciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson and Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pacira BioSciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Luye Pharma Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ipsen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol Myers Squibb
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Evonik Health Care
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fujifilm
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Polymun Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
14. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
15. References and Research Methodology
- References
- Research Methodology
- About us
